ArticleAntimicrobial agents and chemotherapy2009

Apricitabine does not select additional drug resistance mutations in tissue culture in human immunodeficiency virus type 1 variants containing K65R, M184V, or M184V plus thymidine analogue mutations.

Maureen Oliveira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.